MADISON, Wis. , Dec. 12, 2016 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) announced today that under a recently-signed contract, Humana Inc. agreed to cover Cologuard as an in-network service for its members, effective January 1, 2017 . Under terms of the agreement, Cologuard will be available to most Humana beneficiaries with no co-pay. Humana covers nearly 10 million beneficiaries and is the nation’s fifth largest commercial insurer.

“As demand for Cologuard grows, this contract marks an opportunity to increase access to colon cancer screening among Humana’s beneficiaries who now can choose Cologuard and its wrap-around compliance service,” said Kevin Conroy , chairman and CEO of Exact Sciences . “We believe this decision by one of the nation’s largest health insurers reflects a growing understanding that Cologuard can detect more cancers earlier and reduce costs in the health system.”

With Humana’s inclusion of Cologuard as an in-network service, the test is now covered by a cross-section of health plans nationwide with more than 153 million members. This is an increase of more than 50 million members since June 2016 when Cologuard was included as an A-rated service in the colorectal cancer screening guidelines of the U.S. Preventive Services Task Force . More than 68 percent of Cologuard’s addressable population are enrolled in plans that cover the test. Read the full story here.